Cellular signals involved in cyclooxygenase-2 expression induced by human cytomegalovirus

Virus Research

Volumn 146, Issue 1-2, 2009, Pages 89-96

  Yi, Hyun Ah ^a   Kim, Mi Suk ^a   Jang, So Young ^a   Lee, Young Min ^a   Ahn, Jin Hyun ^b   Lee, Chan Hee ^a  

^a Chungbuk National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Human cytomegalovirus; Signaling

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS STRAIN; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; KOREA; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR;

HUMAN HERPESVIRUS 5;

EID: 70350236356     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.09.004     Document Type: Article

References (44)

1. Browne E.P., Wing B., Coleman D., and Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75 (2001) 12319-12330
2. Cha T.A., Tom E., Kemble G.W., Duke G.M., Mocarski E.S., and Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. Virology 70 (1996) 78-83
3. Carpenter G. ErbB-4: mechanism of action and biology. Exp. Cell. Res. 284 (2003) 66-77
4. Citri A., Skaria K.B., and Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell. Res. 284 (2003) 54-65
5. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., and Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77 (2003) 4588-4596
6. Compton T. Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell. Biol. 14 (2004) 5-8
7. Dolan A., Cunningham C., Hector R.D., Hassan-Walker A.F., Lee L., Addison C., Dargan D.J., McGeoch D.J., Gatherer D., Emery V.C., Griffiths P.D., Sinzger C., McSharry B.P., Wilkinson G.W., and Davison A.J. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85 (2004) 1301-1312
8. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
9. Eickhoff J.E., and Cotton M. NF-kappaB activation can mediate inhibition of human cytomegalovirus replication. J. Gen. Virol. l86 (2005) 285-295
10. Eickhoff J.E., Hanke M., Stein-Gerlach M., Kiang T.P., Herzberger K., Habenberger P., Muller S., Klebl B., Marschall M., Stamminger T., and Cotton M. RICK activates an NF-κB dependent anti-HCMV response. J. Biol. Chem. 279 (2004) 9642-9652
11. Evers D.L., Wang X., and Huang E.S. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6 (2004) 1084-1093
12. Feire A.L., Koss H., and Compton T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15470-15475
13. Fortunato E.A., McElroy A.K., Sanchez I., and Spector D.H. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8 (2000) 111-119
14. Hooks J.J., Chin M.S., Srinivasan K., Momma Y., Hooper L.C., Nagineni C.N., Chan C.C., and Detrick B. Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway. Microbes Infect. 8 (2006) 2236-2244
15. Isaacson M.K., Feire A.L., and Compton T. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J. Virol. 81 (2007) 6241-6247
16. Johnson R.A., Ma X.L., Yurochko A.D., and Huang E.S. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 82 (2001) 493-497
17. Johnson R.A., Wang X., Ma X.L., Huong S.M., and Huang E.S. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75 (2001) 6022-6032
18. Johnson R.A., Huong S.M., and Huang E.S. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 74 (2000) 1158-1167
19. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., and Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell. Res. 284 (2003) 31-53
20. Kahl M., Siegel-Axel D., Stenglein S., Jahn G., and Sinzger C. Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol. 74 (2000) 7628-7635
21. Lee K., Jeon K., Kim J.M., Kim V.N., Choi D.H., Kim S.U., and Kim S. Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus. Glia 51 (2005) 1-12
22. Landolfo S., Gariglio M., Gribaudo G., and Lembo D. The human cytomegalovirus. Pharmacol. Ther. 98 (2003) 269-297
23. Lee G.C., Yi H.A., and Lee C.H. Stimulation of interferon-β gene expression by human cytomegalovirus via nuclear factor kappa B and phosphatidylinositol 3-kinase pathway. Virus Res. 117 (2006) 209-214
24. Levi M. CMV endothelitis as a factor in the pathogenesis of atherosclerosis. Cardiovasc. Res. 50 (2001) 432-433
25. Maussang D., Langemeijer E., Fitzsimons C.P., Stigter-van Walsum M., Dijkman R., Borg M.K., Slinger E., Schreiber A., Michel D., Tensen C.P., van Dongen G.A., Leurs R., and Smit M.J. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res. 69 (2009) 2861-2869
26. Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M.R., Carotenuto A., De Feo G., Caponigro F., and Salomon D.S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366 (2006) 2-16
27. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19 (2000) 3159-3167
28. Prichard M.N., Penfold M.E., Duke G.M., Spaete R.R., and Kemble G.W. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11 (2001) 191-200
29. Reynolds A.E., and Enquist L.W. Biological interactions between herpesviruses and cyclooxygenase enzymes. Rev. Med. Virol. 16 (2006) 393-403
30. Rodems S.M., and Spector D.H. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J. Virol. 72 (1998) 9173-9180
31. Schröer J., and Shenk T. Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 19468-19473
32. Speir E., Yu Z.X., Ferrans V.J., Huang E.S., and Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83 (1998) 210-216
33. Soltoff S.P., and Cantley L.C. p120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J. Biol. Chem. 271 (1996) 563-567
34. Streblow D.N., Orloff S.L., and Nelson J.A. Do pathogens accelerate atherosclerosis?. J. Nutr. 131 (2001) 2798S-2804S
35. Sun B., Harrowe G., Reinhard C., Yoshihara C., Chu K., and Zhuo S. Modulation of human cytomegalovirus immediate-early gene enhancer by mitogen-activated protein kinase kinase-1. J. Cell. Biochem. 83 (2001) 563-573
36. Tsai S.H., Liang Y.C., Chen L., Ho F.M., Hsieh M.S., and Lin J.K. Arsenite stimulates cyclooxygenase-2 expression through activating IkappaB kinase and nuclear factor kappaB in primary and ECV304 endothelial cells. J. Cell. Biochem. 84 (2002) 750-758
37. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell. Biol. 38 (2006) 1654-1661
38. Wang X., Huong S.M., Chiu M.L., Raab-Traub N., and Huang E.S. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424 (2003) 456-461
39. Wang X., Huang D.Y., Huong S.M., and Huang E.S. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat. Med. 11 (2005) 515-521
40. Yurochko A.D., Kowalik T.F., Huong S.M., and Huang E.S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 69 (1995) 5391-5400
41. Yurochko A.D. Human cytomegalovirus modulation of signal transduction. Curr. Top. Microbiol. Immunol. 325 (2008) 205-220
42. Zhang Z., Evers D.L., McCarville J.F., Dantonel J.C., Huong S.M., and Huang E.S. Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation. J. Virol. 80 (2006) 3833-3843
43. Zhu H., Cong J.P., Mamtora G., Gingeras T., and Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14470-14475
44. Zhu H., Cong J.P., Yu D., Bresnahan W.A., and Shenk T.E. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3932-3937